Startups
Driven by our mission to unveil the complex mechanisms of cancer and advance precision oncology, Indivumed combines the world’s most comprehensive multi-omics data with extensive medical experience, bioinformatics expertise and AI-integrated advanced analytics. Our global clinical network enables us to collect and analyze thousands of patient samples using a standardized approach to ensure biospecimen quality across three business units – IndivuServ, IndivuTest, and IndivuType. The unparalleled depth and quality of our data – coupled with our robust product and service offerings – gives us the ability to obtain novel insights and accelerate cancer research.
Overview
Location
Germany, Hamburg
Employees
201-500
Total raised
$47.71M
Founded date
2002
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 10, 2025 | Indivumed and University of Rochester Medical Center expand collaboration for patient-centric discovery of novel therapeutics | Two leading entities in cancer research pledge scientific collaboration to advance precision oncology. HAMBURG, Germany and ROCHESTER, N.Y., Dec. 10, 2025 /PRNewswire/ -- Indivumed is excited to announce its partnership with the world-renow... |
| Jun 2, 2021 | Indivumed Launches the nRavel™ AI Platform for Cancer Research and Drug Development | |
| Mar 18, 2021 | Indivumed Announces Expansion Into Drug Development, Formation of Ix Therapeutics USA - English España - español | |
| Sep 3, 2020 | Indivumed Announces Global Expansion of Clinical Network to Grow IndivuType Database | |
| Jan 9, 2018 | Indivumed Receives €40M Loan | Indivumed GmbH, a Hamburg, Germany-based physician-led, integrated global oncology company, received a €40m loan. The European Investment Bank (EIB) provided the financial resources. The EIB funding will allow the company to develop and val... |
Reviews 0
FAQ about Indivumed Group
When was Indivumed Group founded?
Indivumed Group was founded in 2002.
How much funding has Indivumed Group raised?
Indivumed Group has raised $47.71M in total across 1 funding round.
What has the press written about Indivumed Group?
Parsers VC has collected 6 articles mentioning Indivumed Group, among them “Indivumed and University of Rochester Medical Center expand collaboration for patient-centric discovery of novel therapeutics” (Dec 10, 2025) and “Indivumed Launches the nRavel™ AI Platform for Cancer Research and Drug Development” (Jun 2, 2021).
Is Indivumed Group still active?
Yes, Indivumed Group is active; its latest activity on Parsers VC dates from Dec 10, 2025.